HOME Research Insight Key Players in the Single-cell analysis Market Focus on New Product Launches, Partnerships, Agreements, & Collaborations, Acquisitions, and Approvals



Key Players in the Single-cell analysis Market Focus on New Product Launches, Partnerships, Agreements, & Collaborations, Acquisitions, and Approvals


The single-cell analysis market is consolidated in nature due to the presence of a few large players. The prominent players in the single-cell analysis market include Thermo Fisher Scientific Inc. (U.S.)., Illumina, Inc, (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Nanostring Technologies (U.S.),Beckman Coulter (U.S.), Fluidigm Corporation (U.S.), Merck KGaA (Germany) and QIAGEN N.V. (Netherlands).

Thermo Fisher Scientific Inc. (U.S.) was the global leader in the single-cell analysis market in 2015. It is a well-known company and has an exhaustive product portfolio. The company is innovation-centric and invests heavily in R&D for maintaining its market share. Moreover, the company focuses on inorganic growth strategies such as acquisitions for enhancing its market share. In February 2013, Thermo Fisher Scientific acquired Life Technologies, a leading player in the life sciences business to expand its product offerings.

Illumina, Inc. (U.S.) held the second position in the global single-cell analysis market in 2015. Illumina focuses on new product development as its key strategy to gain a competitive edge in the single-cell analysis market. For instance, in January 2016, the company launched the MiniSeq Sequencing System, addition to its industry leading NGS portfolio. MiniSeq Sequencing System performs target sequencing with push-button operation.

QIAGEN N.V. (Netherlands), held the third-largest player in the global single-cell analysis market in 2015. QIAGEN focuses on collaborations to increase its market share. For instance, in February 2016, QIAGEN collaborated with 10X Genomics to support advances in the field of NGS and single-cell biology.

The key strategies followed by most companies in the single-cell analysis market are new product launches; partnerships, agreements, collaborations; acquisitions; and approvals. The strategy of new product launches accounted for the largest share of the overall growth strategies mapped from 2013 to 2016. Some of the leading players that adopted this strategy include Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Qiagen N.V. (Netherlands), Becton, Dickinson and Company (BD) (U.S.) and Bio-Rad (U.S.). Partnerships, agreements, collaborations accounted for the second-largest share of the overall growth strategies adopted by players in this market.

Related Reports:

Single-Cell Analysis Market by Product (Beads, Microplate, Reagents, Flow Cytometer, Microscope, Spectrophotometer), Cell Type (Human, Animal), Technique (NGS, PCR), Application (Cancer, Neurology, NIPD, IVF, CTCs) & End User - Global Forecasts to 2021

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports